Clinical Trials Logo

Arteriosclerosis clinical trials

View clinical trials related to Arteriosclerosis.

Filter by:

NCT ID: NCT00352937 Completed - Clinical trials for Coronary Arteriosclerosis

Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test

Start date: March 2006
Phase: Phase 3
Study type: Observational

To compare the efficacy of 16-row multi-detector CT (MDCT) with standard myocardial perfusion imaging in detecting coronary artery disease (CAD) in patients without a previously established diagnosis of CAD.

NCT ID: NCT00351676 Completed - Clinical trials for Diabetes Mellitus, Type 2

Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment

Start date: February 2006
Phase: Phase 4
Study type: Interventional

We, the researchers, propose to link a clinical pharmacist with an internal medicine or family medicine team to provide pharmaceutical care to all patients assigned to the team. The hypothesis is that through this team based approach, pharmacists will act as a resource for providing pharmacotherapeutic advice during the drug therapy decision making process and promote optimal drug use by identifying and resolving actual and potential drug related problems. This study is designed to test this hypothesis, by assessing the impact of this intervention on evidence based, quality of drug therapy indicators, for patients admitted with heart failure (HF), chronic obstructive pulmonary disease (COPD), community acquired pneumonia (CAP), type 2 diabetes mellitus (T2DM), and stable coronary artery disease (CAD).

NCT ID: NCT00345631 Completed - Clinical trials for Coronary Arteriosclerosis

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the Ensure Medical Vascular Closure Device is more effective than standard manual compression at sealing the puncture made in the femoral artery following a cardiac or peripheral diagnostic or interventional procedure while maintaining the same level of safety.

NCT ID: NCT00328848 Completed - Hypertension Clinical Trials

After Discharge Management of Low Income Frail Elderly

Start date: October 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether comprehensive post-hospitalization interdisciplinary care management can be an effective care delivery model to improve outcomes in low-income frail elderly.

NCT ID: NCT00325611 Completed - Stroke Clinical Trials

Multidisciplinary Inpatient Palliative Care Intervention

Start date: April 2002
Phase: N/A
Study type: Interventional

Palliative care is believed to improve care of patients with life-limiting illnesses. This study evaluated the impact of a multi-center randomized trial of a palliative care team intervention on the quality and cost of care of hospitalized patients. Study subjects were randomized to intervention or usual care. At study end, patients receiving the palliative care intervention reported greater patient satisfaction with their care. Intervention patients also had significantly fewer ICU admissions and lower total costs for care 6 months past their hospitalization. Intervention patients completed more advance directives and had longer hospice stays.

NCT ID: NCT00319449 Completed - Clinical trials for Hypercholesterolemia

Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

Start date: September 2005
Phase: Phase 4
Study type: Interventional

This study is being conducted to compare the efficacy, safety, and tolerability of ezetimibe 10 mg coadministered with atorvastatin 10 mg versus atorvastatin 10 mg in Indonesian population with primary hypercholesterolemia.

NCT ID: NCT00316108 Completed - Stroke Clinical Trials

Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)

BEACH
Start date: February 2002
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether morbidity and mortality for high-risk surgical patients treated with the Carotid Wallstent in conjunction with the FilterWire EX and EZ System distal protection device will be less than or equal to that of objective performance criteria (OPC) derived from historic controls undergoing surgical intervention with a carotid endarterectomy (CEA).

NCT ID: NCT00300157 Completed - Clinical trials for Coronary Arteriosclerosis

Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent

Start date: December 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether percutaneous coronary angioplasty with Taxus drug eluting stent is safe and effective in the treatment of unprotected left main coronary artery disease associated to other coronary lesions or not.

NCT ID: NCT00297219 Completed - Hemodialysis Clinical Trials

Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry

Start date: November 2005
Phase: N/A
Study type: Interventional

The high rate of cardiovascular complications in the dialysis population cannot be explained by traditional cardiovascular risk factors. One of such factors proposed to contribute to the cardiovascular mortality in dialysis patient population is vascular calcification possibly resulting from disturbances of calcium-phosphate metabolism. The aim of this study is to assess the effects of treatment with dialysate containing 1.75 or 1.5 mmol/L to 1.25 mmol/L calcium regarding coronary artery calcification and bone histomorphometry in hemodialysis patients.

NCT ID: NCT00292721 Completed - Clinical trials for Coronary Arteriosclerosis

Effects of Celecoxib After Percutaneous Coronary Intervention

Start date: August 2004
Phase: Phase 4
Study type: Interventional

Several studies including ours have reported that celecoxib improves endothelium-dependent vasodilation and reduces inflammation and neointimal hyperplasia. Our hypothesis is that celecoxib may reduce the late luminal loss after coronary stent implantation (paclitaxel-eluting stent.